Health Care Select Sector SPDR Fund : XLV

Price Target

›

XLV

Stock Data

$145.16

$0.83 (0.57%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

All XLV Articles

15 Articles

Austin Smith | Apr 29, 2026 at 7:23 AM EDT

Healthcare’s Defensive Promise Crumbles: XLV Down 7% While SPY Rises 5% in 2026

Healthcare is supposed to be the place you hide. It is the fourth-largest slice of U.S. GDP at 8.9% in…

Michael Williams | Mar 26, 2026 at 2:32 PM EDT

VHT Lagged the Market by 57 Points Over 5 Years. Here Is Why Long-Term Investors Still Hold It

Healthcare spending doesn’t stop during recessions. That structural reality is the core argument for owning Vanguard Health Care ETF (NYSEARCA:VHT…

Joel South | Mar 17, 2026 at 11:56 AM EDT

Why One Analyst Thinks Johnson & Johnson Reaches $280

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) has been one of healthcare’s standout performers over the past year, with…

Tony Dong | Mar 9, 2026 at 9:33 AM EDT

The “Cockroach” Portfolio: Why This 5-ETF Strategy Is Every Retiree’s Best Defense Against a 2026 Recession

Talk of a recession is once again dominating the headlines. The latest job report has just been released, showing a…

Austin Smith | Feb 18, 2026 at 5:32 AM EST

XLV is A $41 Billion Defensive Healthcare Play That Looks Good Until You Compare To The S&P 500

Healthcare isn’t going anywhere. An aging population, chronic disease management, and breakthrough treatments ensure this sector remains essential regardless of…

Joey Frenette | Jan 29, 2026 at 12:16 PM EST

2 Hot Sector ETFs Worth Buying in 2026

Index investors and so-called Bogleheads (those who love the Vanguard ETFs) may not be all too fond of the sector…

Michael Williams | Jan 29, 2026 at 8:20 AM EST

PINK’s 58% Gains Since 2021 Come From Picking Winners, Not Owning Everything

Healthcare is supposed to be defensive. When tech stocks swing wildly and consumer spending wobbles, healthcare companies keep selling drugs,…

John Seetoo | Jan 8, 2026 at 8:48 AM EST

3 Top ETFs To Profit As Investors Move Away From Big Tech in 2026

Defensive stocks are defined as the stocks in companies that are grouped in sectors supplying goods and services in constant…

Omor Ibne Ehsan | Dec 16, 2025 at 12:41 PM EST

These 3 Dividend ETFs Outperformed Every Market Crash Since 2000

If you are an investor who is securing profits and is buying up dividend ETFs to weather a possible downturn…

Rich Duprey | Mar 26, 2025 at 11:52 AM EDT

The 5 Biggest Risks to JEPI’s 7.4% Dividend Yield

The JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI) has become a go-to for investors chasing steady income with a side of…

Joey Frenette | Mar 7, 2025 at 7:11 AM EST

At 35 I should know more about my Roth IRA than I do, but am risk-averse and worried about retirement

If you’re 35 and growing a bit anxious about the prospect of retirement, do not fret as many Millennials, some…

Jon C. Ogg | Dec 7, 2016 at 12:40 PM EST

Trump’s Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares

Trump told Time that he wants to lower drug prices, a move that has hit the drug and biotech segments…

Jon C. Ogg | Aug 28, 2013 at 6:44 AM EDT

Five Ways Hedge Funds Brace for a Stock Market Crash, and You Can Too

thinkstockInvestors almost always worry about a stock market crash, but when headwinds start to look stronger than the positive forces,…

Jon C. Ogg | Jun 28, 2012 at 10:38 AM EDT

Supreme Court Rules on Healthcare, The Fallout By Sector (Updated)

Thursday was D-Day for the Supreme Court decision on the Obama healthcare mandate as to its constitutionality. The long and…

Jon C. Ogg | Dec 28, 2011 at 2:46 PM EST

ETFs Winning & Losing Fund Flows Into Year-End (GLD, XLV, FXI, SPY, XLK, EFA)

TrimTabs is showing what many investors might have expected. After such a volatile year in the stock market, investors are seeking…

Health Care Select Sector SPDR Fund : XLV

XLV

$145.16

All XLV Articles

Healthcare’s Defensive Promise Crumbles: XLV Down 7% While SPY Rises 5% in 2026

VHT Lagged the Market by 57 Points Over 5 Years. Here Is Why Long-Term Investors Still Hold It

Why One Analyst Thinks Johnson & Johnson Reaches $280

The “Cockroach” Portfolio: Why This 5-ETF Strategy Is Every Retiree’s Best Defense Against a 2026 Recession

XLV is A $41 Billion Defensive Healthcare Play That Looks Good Until You Compare To The S&P 500

2 Hot Sector ETFs Worth Buying in 2026

PINK’s 58% Gains Since 2021 Come From Picking Winners, Not Owning Everything

3 Top ETFs To Profit As Investors Move Away From Big Tech in 2026

These 3 Dividend ETFs Outperformed Every Market Crash Since 2000

The 5 Biggest Risks to JEPI’s 7.4% Dividend Yield

At 35 I should know more about my Roth IRA than I do, but am risk-averse and worried about retirement

Trump’s Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares

Five Ways Hedge Funds Brace for a Stock Market Crash, and You Can Too

Supreme Court Rules on Healthcare, The Fallout By Sector (Updated)

ETFs Winning & Losing Fund Flows Into Year-End (GLD, XLV, FXI, SPY, XLK, EFA)

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

Health Care Select Sector SPDR Fund : XLV

XLV

$145.16

All XLV Articles

Healthcare’s Defensive Promise Crumbles: XLV Down 7% While SPY Rises 5% in 2026

VHT Lagged the Market by 57 Points Over 5 Years. Here Is Why Long-Term Investors Still Hold It

Why One Analyst Thinks Johnson & Johnson Reaches $280

The “Cockroach” Portfolio: Why This 5-ETF Strategy Is Every Retiree’s Best Defense Against a 2026 Recession

XLV is A $41 Billion Defensive Healthcare Play That Looks Good Until You Compare To The S&P 500

2 Hot Sector ETFs Worth Buying in 2026

PINK’s 58% Gains Since 2021 Come From Picking Winners, Not Owning Everything

3 Top ETFs To Profit As Investors Move Away From Big Tech in 2026

These 3 Dividend ETFs Outperformed Every Market Crash Since 2000

The 5 Biggest Risks to JEPI’s 7.4% Dividend Yield

At 35 I should know more about my Roth IRA than I do, but am risk-averse and worried about retirement

Trump’s Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares

Five Ways Hedge Funds Brace for a Stock Market Crash, and You Can Too

Supreme Court Rules on Healthcare, The Fallout By Sector (Updated)

ETFs Winning & Losing Fund Flows Into Year-End (GLD, XLV, FXI, SPY, XLK, EFA)

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

Featured Reads

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not